Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AgfiledCriticalNovartis Ag
Publication of CR20120083ApublicationCriticalpatent/CR20120083A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se dan a conocer derivados de oxazina de la fórmula (I): los cuales tienen una actividad inhibidora de BACE, en donde todas las variables son como se definen en la memoria descriptiva, en forma libre o en forma de sal, sus métodos de preparación, su uso médico, y medicamentos que los comprenden.Oxazine derivatives of the formula (I) are disclosed: which have a BACE inhibitory activity, where all the variables are as defined in the specification, in free form or in salt form, their preparation methods , their medical use, and medications that comprise them.
CR20120083A2010-07-132012-02-17
DERIVATIVES OF OXAZINE AND ITS USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS
CR20120083A
(en)